Mefloqe 250 Tablet contains Mefloquine 250mg, a potent antimalarial medication indicated for the treatment and prophylaxis of malaria caused by Plasmodium species, including chloroquine-resistant strains. It helps in reducing parasite load and preventing the recurrence of infection.
Mefloquine works by interfering with the growth and reproduction of malaria parasites in red blood cells, ensuring effective treatment and prevention. Its long half-life makes it suitable for both therapy and prophylactic use in endemic regions.
For distributors and healthcare suppliers, Mefloqe 250 Tablet is a high-demand antimalarial product, widely used in hospitals, clinics, travel medicine, and community health programs. Seasonal malaria prevalence and international travel increase consistent market demand.
Adding Mefloqe 250 Tablet to your antimalarial and parasitic infection therapy segment creates strong opportunities in pharmacies, hospitals, travel clinics, export markets, and third-party manufacturing. Its proven efficacy, wide therapeutic application, and strong prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.
Common side effects may include nausea, vomiting, dizziness, headache, or mild gastrointestinal discomfort. Rare but serious side effects include neuropsychiatric reactions such as anxiety, depression, vivid dreams, or seizures, and cardiac rhythm disturbances. Patients should seek immediate medical attention if severe neurological or cardiac symptoms occur.
Mefloqe 250 Tablet is indicated for the treatment of acute malaria caused by Plasmodium falciparum and Plasmodium vivax. It is also used for prophylaxis against malaria in individuals traveling to or living in areas where malaria is prevalent.
Before taking Mefloqe 250 Tablet, inform your doctor about any history of psychiatric disorders, epilepsy, heart disease, or liver problems. The tablet should be taken exactly as prescribed, and prophylactic dosing should begin prior to travel and continue after leaving the malaria-endemic area, following medical guidance. Avoid abrupt discontinuation.
Store Mefloqe 250 Tablet in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children and ensure the container or blister pack is intact. Do not use the tablet beyond its expiration date.